SecBot SecBot
144 ·Filed Jun 25, 2026

VTRS

Viatris Inc
NEUTRAL
Impact 3/10
Horizondays Processed4mo ago SEC0001628280-26-045540
Form 144, notice of proposed sale of securities
Actionable Insight • Neutral

The proposed sale is small relative to Viatris's market cap and relates to shares acquired through compensation vesting, not open-market accumulation being unwound. This is likely a routine liquidity event. Monitor for actual execution on Form 4 filings, but the 144 alone does not warrant a directional trade.

DirectionNeutral
Confidencemedium
Horizondays

How the stock moved after the report

NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+60
Entry
$16.33
T+0 close · Jun 25, 2026 · via day close
Latest settled
+4.72%
T+60 · $17.10
Vs SPY
−1.39%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · Jun 26 $16.33entry
  2. T+1 · 5mo ago −0.61%α −2.26% · $16.23
  3. T+5 · 4mo ago +2.27%α +0.10% · $16.70
  4. T+20 · 4mo ago +5.82%α +4.56% · $17.28
  5. T+60 · 8w ago +4.72%α −1.39% · $17.10
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Viatris officer Paul Campbell filed a Form 144 notice of intent to sell 50,076 shares of common stock, with an approximate market value of $809,678 based on the filing date. The shares being sold were acquired through vesting of stock awards in March 2023 and March 2024, suggesting routine portfolio diversification rather than a discretionary bearish signal.

Key Facts

  • Form 144 filed June 25, 2026 by officer Paul Campbell for the sale of 50,076 shares.
  • Estimated dollar value of proposed sale: $809,677.94 at approximately $16.17/share.
  • Shares were acquired via vesting of stock awards on 03/04/2023 (361 shares) and 03/02/2024 (49,715 shares) as compensatory payments.
  • Broker for the proposed sale is Merrill Lynch.
  • Viatris has a market cap of $18.6B with 67% analyst bullish rating.

Financial Impact

Proposed sale of 50,076 shares (~$810K) represents about 0.004% of Viatris's $18.6B market cap, de minimis.

dilutioninsider holdings

Risk Factors

  • Form 144 is a notice of intent, the sale may not be executed, but its filing signals the insider considered selling.

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
67% bullish (18 analysts)

Investment Themes

Documents Analyzed

This report is based on 3 SEC documents filed with EDGAR.

DocumentAccession Number
144 Filing (Primary)0001628280-26-045540
Document: 0001628280-26-045540-index.html0001628280-26-045540
Document: 0001628280-26-045540.txt0001628280-26-045540

US Market Status

Market Open · Closes in 40m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Jun 25, 2026